🇺🇸 FDA
Patent

US 9233095

Small molecule RNase inhibitors and methods of use

granted A61KA61K31/341A61K31/402

Quick answer

US patent 9233095 (Small molecule RNase inhibitors and methods of use) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/341, A61K31/402, A61K31/427, A61K45/06